Location History:
- Basel, CH (2007)
- Berlin, DE (2004 - 2008)
Company Filing History:
Years Active: 2004-2008
Title: Innovations by Alexander Ernst: Pioneering Medicinal Chemistry
Introduction
Alexander Ernst is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of pharmaceutical agents targeting diseases associated with persistent angiogenesis. With a total of six patents to his name, Ernst's work has the potential to impact various medical conditions.
Latest Patents
Ernst's latest patents include innovative compounds such as N-oxide anthranylamide derivatives and cyanoanthranilamide derivatives. These compounds are designed for use as medicaments in treating a range of diseases, including psoriasis, Kaposi's sarcoma, and various forms of arthritis. The N-oxide anthranylamide derivatives are particularly noteworthy for their application in conditions like diabetic retinopathy and renal diseases. Similarly, the cyanoanthranilamide derivatives are aimed at addressing issues related to restenosis and fibrotic diseases. Both classes of compounds also serve as VEGFR-3 inhibitors, which are crucial in managing lymphangiogenesis.
Career Highlights
Throughout his career, Alexander Ernst has worked with prominent companies, including Schering Aktiengesellschaft. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.
Collaborations
Ernst has collaborated with notable colleagues such as Martin Haberey and Andreas Huth. These partnerships have likely contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Alexander Ernst's contributions to medicinal chemistry through his innovative patents highlight his role as a significant inventor in the field. His work continues to pave the way for new treatments for complex medical conditions.